期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
大肠癌患者手术前后淋巴细胞表型CD49b、CD49d的测定及其临床意义 被引量:1
1
作者 陈腾 施靖华 +2 位作者 赵荣华 李华宝 李莉 《肿瘤防治研究》 CAS CSCD 2003年第6期511-512,共2页
关键词 大肠癌 手术前 淋巴细胞表型 cd49b CD49D 测定
暂未订购
反复自发性流产患者外周血CD14~+细胞表面CD49b和淋巴细胞活化基因3表达水平降低 被引量:4
2
作者 曾汉玉 刘媛 +2 位作者 郭雯娓 王晓红 陈丽华 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2016年第3期369-372,377,共5页
目的观测黏附分子CD49b和负性调节分子淋巴细胞活化基因3(LAG-3)在反复自发性流产(RSA)患者CD14+细胞上的表达。方法收集7例正常对照者和12例RSA患者外周血5 m L,分离外周血单个核细胞(PBMC)和血浆,流式细胞术检测PBMC中CD14+细胞表面CD... 目的观测黏附分子CD49b和负性调节分子淋巴细胞活化基因3(LAG-3)在反复自发性流产(RSA)患者CD14+细胞上的表达。方法收集7例正常对照者和12例RSA患者外周血5 m L,分离外周血单个核细胞(PBMC)和血浆,流式细胞术检测PBMC中CD14+细胞表面CD49b和LAG-3的表达;ELISA检测血浆中细胞因子白细胞介素10(IL-10)和转化生长因子β(TGF-β)的水平。结果 RSA患者外周血中,单核细胞的比例与正常对照组相比无显著性差异;CD14+CD49b+、CD14+LAG-3+、CD14+CD49b+LAG-3+细胞的百分比均低于正常对照组。血浆中,TGF-β的水平低于正常对照组;IL-10的水平无显著差异。结论 RSA患者外周血CD14+细胞表面CD49b和LAG-3的表达和血浆中TGF-β的水平均显著降低。 展开更多
关键词 反复自发性流产 单核细胞 cd49b 淋巴细胞活化基因3(LAG-3) 转化生长因子Β IL-10
原文传递
人胎盘来源的间充质干细胞诱导CD4^+CD45RA^-CD49b^+LAG3^+Tr1细胞增殖研究 被引量:1
3
作者 张焕婷 池颖 +1 位作者 韩之波 曹晓沧 《中国医药导报》 CAS 2017年第6期8-11,23,共5页
目的研究人胎盘来源的间充质干细胞(MSC)是否能诱导正常人外周血单个核细胞(PBMC)中CD4+CD45RACD49b+LAG3+Tr1细胞增殖。方法分离、纯化、表型鉴定人胎盘来源的MSC。实验分组如下:PBMC组、PBMC+MSC组、CD3+CD28+PBMC组和MSC+CD3+CD28+P... 目的研究人胎盘来源的间充质干细胞(MSC)是否能诱导正常人外周血单个核细胞(PBMC)中CD4+CD45RACD49b+LAG3+Tr1细胞增殖。方法分离、纯化、表型鉴定人胎盘来源的MSC。实验分组如下:PBMC组、PBMC+MSC组、CD3+CD28+PBMC组和MSC+CD3+CD28+PBMC组。相同条件下培养24 h后,流式细胞术检测各组CD4^+CD45RA^-CD49b^+LAG3^+Tr1细胞比例;ELISA法检测各组上清中白细胞介素10(IL-10)水平,并对MSC+CD3+CD28+PBMC组中的CD4^+CD45RA^-CD49b^+LAG3^+Tr1比例和其上清中IL-10含量作相关性分析。结果MSC+CD3+CD28+PBMC组中CD4^+CD45RA^-CD49b^+LAG3^+Tr1细胞比例为(6.66±2.80)%,PBMC组为(1.01±0.44)%,PBMC+MSC组为(1.14±0.78)%,CD3+CD28+PBMC组为(4.20±2.58)%,差异有统计学意义(P<0.05)。MSC+CD3+CD28+PBMC组上清中的IL-10含量为(14.45±3.14)pg/m L,PBMC组为(0.90±0.05)pg/m L,PBMC+MSC组为(11.00±3.02)pg/m L,CD3+CD28+PBMC组为(6.04±1.90)pg/m L,差异有统计学意义(P<0.05)。MSC+CD3+CD28+PBMC组中的CD4+CD45RACD49b+LAG3+Tr1比例与其上清中IL-10含量成正相关(r=0.880,P<0.01)。结论 MSC可以诱导CD3、CD28活化的PBMC细胞中的CD4^+CD45RA^-CD49b^+LAG3^+Tr1细胞增殖,CD4^+CD45RA^-CD49b^+LAG3^+Tr1细胞比例增加与上清中IL-10水平升高有关。 展开更多
关键词 间充质干细胞 外周血单个核细胞 白介素10 CD4+CD45RA—cd49b+LAG3+Tr1细胞
暂未订购
基于蛋白质组学联合转录组学的肺腺癌预后模型和标志物研究
4
作者 严循东 张先稳 《实用临床医药杂志》 2025年第3期30-37,共8页
目的基于蛋白质组学和转录组学筛选肺腺癌预后生物标志物并构建预后模型。方法从TCGA公共数据库下载肺腺癌的蛋白质组学、转录组学及患者临床特征数据。按照7∶3比例将数据集分成训练组和验证组。根据患者临床生存时间、生存状态和蛋白... 目的基于蛋白质组学和转录组学筛选肺腺癌预后生物标志物并构建预后模型。方法从TCGA公共数据库下载肺腺癌的蛋白质组学、转录组学及患者临床特征数据。按照7∶3比例将数据集分成训练组和验证组。根据患者临床生存时间、生存状态和蛋白表达数据,在训练集中进行蛋白表达单因素预后分析。采用Lasso-step Cox方法,构建肺腺癌患者预后模型,并计算风险分数。根据风险分数中位数将患者分为高风险组和低风险组,并分析2组预后情况。构建预后列线图模型和校准曲线,对该模型进行临床分组验证和相关性分析。基于HPA数据库分析模型蛋白表达情况,并对风险蛋白进行富集分析。选取20例初诊肺腺癌患者进行免疫组化和临床特征分析。结果本研究筛选出5个与预后相关的蛋白,构建了风险蛋白模型。风险分数对肺腺癌患者的预后具有预测作用。该风险模型展现出较强且独立的预后预测能力。列线图模型在预测个体预后方面表现出较高的准确性。此外,风险模型及其计算出的风险分数与临床分期特征之间存在内在联系。HPA数据库分析表明,CD38、CD49B、ADAR1和cdc25C4在肺腺癌组织中显著高表达。20例临床标本验证了初诊肺腺癌远处转移患者的CD49B呈高表达,且对治疗较敏感。结论蛋白质组学和转录组学联合分析肺腺癌预后标志物的结果较可靠。CD49B在肺腺癌中发挥重要作用,基于该基因构建的预后预测模型有望为临床治疗肺腺癌提供重要参考。 展开更多
关键词 蛋白质组学 转录组学 肺腺癌 cd49b蛋白 TCGA公共数据
在线阅读 下载PDF
Regulation and functions of integrin a2 in cell adhesion and disease 被引量:11
5
作者 Valery Adorno-Cruz Huiping Liu 《Genes & Diseases》 SCIE 2019年第1期16-24,共9页
Integrins are cell adhesion molecules that are composed of an alpha(a)subunit and a beta(b)subunit with affinity for different extracellular membrane components.The integrin family includes 24 known members that activ... Integrins are cell adhesion molecules that are composed of an alpha(a)subunit and a beta(b)subunit with affinity for different extracellular membrane components.The integrin family includes 24 known members that actively regulate cellular growth,differentiation,and apoptosis.Each integrin heterodimer has a particular function in defined contexts as well as some partially overlapping features with other members in the family.As many reviews have covered the general integrin family in molecular and cellular studies in life science,this review will focus on the specific regulation,function,and signaling of integrin a2 subunit(CD49b,VLA-2;encoded by the gene ITGA2)in partnership with b1(CD29)subunit in normal and cancer cells.Its roles in cell adhesion,cell motility,angiogenesis,stemness,and immune/blood cell regulations are discussed.The pivotal role of integrin a2 in many diseases such as cancer suggests its potential to be used as a novel therapeutic target. 展开更多
关键词 Integrin a2 cd49b Molecular mechanisms REGULATION SIGNALING
原文传递
ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis 被引量:7
6
作者 Valery Adorno-Cruz Andrew D.Hoffmann +5 位作者 Xia Liu Nurmaa K.Dashzeveg Rokana Taftaf Brian Wray Ruth A.Keri Huiping Liu 《Genes & Diseases》 SCIE 2021年第4期493-508,共16页
Cancer metastasis is largely incurable and accounts for 90%of breast cancer deaths,especially for the aggressive basal-like or triple negative breast cancer(TNBC).Combining patient database analyses and functional stu... Cancer metastasis is largely incurable and accounts for 90%of breast cancer deaths,especially for the aggressive basal-like or triple negative breast cancer(TNBC).Combining patient database analyses and functional studies,we examined the association of integrin family members with clinical outcomes as well as their connection with previously identified microRNA regulators of metastasis,such as miR-206 that inhibits stemness and metastasis of TNBC.Here we report that the integrin receptor CD49b-encoding ITGA2,a direct target of miR-206,promotes breast cancer stemness and metastasis.ITGA2 knockdown sup-pressed self-renewal related mammosphere formation and pluripotency marker expression,in-hibited cell cycling,compromised migration and invasion,and therefore decreased lung metastasis of breast cancer.ITGA2 overexpression reversed miR-206-caused cell cycle arrest in G1.RNA sequencing analyses revealed that ITGA2 knockdown inhibits genes related to cell cycle regulation and lipid metabolism,including CCND1 and ACLY as representative targets,respectively.Knockdown of CCND1 or ACLY inhibits mammosphere formation of breast cancer cells.Overexpression of CCND1 rescues the phenotype of ITGA2 knockdown-induced cell cycle arrest.ACLY-encoded ATP citrate lyase is essential to maintain cellular acetyl-CoA levels.CCND1 knockdown further mimics 1TGA2 knodkdown in abolishing lung colonization of breast cancer cells.We identified that the low levels of miR-206 as well as high expression levels of 1TGA2,ACLY and CCND1 are associated with an unf avor able relapse-free survival of the pa-tients with estrogen receptor-negative or high grade breast cancer,especially basal-like or TNBC,possibly serving as potential biomarkers of cancer stemness and thera peutic targets of breast cancer metastasis. 展开更多
关键词 ACLY Breast cancer CCND1 cd49b INTEGRINS ITGA2 METASTASIS STEMNESS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部